Recent News for MRV - Nuvo Pharmaceuticals Inc

Date Title
May 3 Miravo Healthcare™ Announces First Quarter 2021 Results Release Date and Virtual Annual Meeting of Shareholders
Apr 21 Miravo Healthcare™ Files Final Base Shelf Prospectus
Apr 19 Keynotes, Educational Panels and 66 Companies to Present at the Planet MicroCap Showcase: VIRTUAL on April 20-22, 2021
Apr 12 Miravo Healthcare(TM) to Present at the Planet MicroCap Showcase: VIRTUAL on Thursday, April 22, 2021 at 10:00 a.m. EST
Apr 9 Miravo Healthcare™ to Present at Upcoming Investor Conferences
Mar 26 Miravo Healthcare™ Acknowledged In The Globe and Mail's Second-Annual Women Lead Here Benchmark of Executive Gender Diversity
Mar 19 Government of Canada helps two Lanaudière manufacturing businesses enhance their productivity
Mar 11 Miravo Healthcare to present at the Q1 Virtual Investor Summit
Mar 11 Miravo Healthcare™ to Present at Q1 Virtual Investor Summit
Mar 10 Earnings Update: Here's Why Analysts Just Lifted Their Nuvo Pharmaceuticals Inc. (TSE:MRV) Price Target To CA$2.60
Mar 8 Miravo Healthcare™ Files Preliminary Base Shelf Prospectus
Mar 8 Miravo Healthcare™ Announces 2020 and Fourth Quarter Results
Mar 1 Miravo Healthcare™ Ireland Enters into Resultz® License and Supply Agreement with The Mentholatum Company for the United States
Feb 22 Miravo Healthcare™ Announces Fourth Quarter 2020 Results Release Date and Conference Call Details
Jan 14 Miravo Healthcare™ to Host Investor Webcast on January 28, 2021 at 2:00 p.m. EST
Jan 13 Miravo Healthcare™ Announces the Canadian Commercial Launch of NeoVisc®+ and NeoVisc® ONE for the Treatment of Pain and Improvement of Joint Functionality of the Knee
Back to the Main MRV Page...